Nerima-ku, Japan Clinical Trials

A listing of Nerima-ku, Japan clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 6 clinical trials
Safety and Efficacy of Dexmedetomidine (DEX) for Sedation of Subjects 1 Month to <17 Years Undergoing MRI Scans

This is a randomized, double-blind, dose-ranging study of the efficacy and safety of dexmedetomidine (DEX) when used with propofol as needed, for procedural sedation of pediatric subjects 1 month to <17 years of age undergoing MRI scans in the US and Japan.

National Center for Child Health and Development
 (7.4 away) Contact site
  • 5 views
  • 13 Jun, 2021
  • +34 other locations
Radium-223 Dichloride Long-term Follow-up Program

Patients will be followed up in this study after prior treatment with BAY88-8223 / Radium-223 dichloride / Xofigo .

 (5.9 away) Contact site
  • 0 views
  • 29 May, 2021
  • +130 other locations
Japanese Primary Prevention Project With Aspirin

The purpose of this study is to investigate the balance between the risks and benefits of primary prevention by Aspirin in elderly Japanese patients with one or more cerebro/cardiovascular risk factors

hypertension
coronary artery disease
hdl cholesterol
hypercholesterolemia
cholesterol measurement
Keio University School of Medicine
 (5.3 away) Contact site
  • 17 views
  • 07 Nov, 2020
  • 1 location
Durvalumab Long-Term Safety and Efficacy Study

The aims of the study are to monitor the long-term safety of durvalumab, to provide continued treatment or retreatment with durvalumab to eligible patients, and to collect overall survival (OS) information.

cancer treatment
antineoplastic
Research Site
 (6.0 away) Contact site
  • 23 views
  • 13 Jun, 2021
  • +164 other locations
A Study to Test How Well Empagliflozin Works in Japanese People With Type 2 Diabetes Who Are Older Than 65 Years

This study is to assess the efficacy of empagliflozin 10 mg after 52 weeks compared to placebo in elderly patients with Type 2 diabetes mellitus (T2DM) and to explore if empagliflozin has any impact on patient physical condition compared to placebo in elderly patients with T2DM.

hypoglycemia
thiazolidinedione
empagliflozin
glucagon
sulfonylurea
Ikebukuro Metropolitan Clinic
 (3.0 away) Contact site
  • 0 views
  • 28 May, 2021
  • +17 other locations
Benefits of Switching Antidepressants Following Early Nonresponse

Introduction and Purpose: Most of the guidelines for the treatment of major depression recommend the use of antidepressants for 4 to 8 weeks. On the other hand, it has been recently reported that they start to show their antidepressant efficacy within a couple of weeks (1,2), contrary to the conventional …

antidepressants
suicidal
remission
sertraline
paroxetine
Oizumi Hospital
 (4.6 away) Contact site
  • 7 views
  • 07 Nov, 2020
  • 1 location